In view of the high rates of both ready-made meal consumption and obesity, further follow-up data and intervention-based trials are required to fight against obesity and associated metabolic risk.
However these results are based on lesser quality studies and conclude that further large randomised trials are required to comprehensively establish this outcome [ 8, 9].
Prospective trials are required to assess whether dosing adjustments based on leucopenia may improve chemotherapy efficacy.
Well-designed prospective trials are required to improve the current weak evidence base.
Hence, large trials are required.
Large-scale trials are required to produce Level 1a evidence.
Larger clinical trials are required to validate these findings.
Further evaluation in the form of randomised trials are required.
Randomized clinical trials are required to support these preliminary findings.
Additional well-designed randomized control trials are required.
Further large-scale prospective clinical trials are required.
